Epidemiological factors influencing the emergence of antimicrobial resistance.

Ciba Foundation symposium Pub Date : 1997-01-01
M L Cohen
{"title":"Epidemiological factors influencing the emergence of antimicrobial resistance.","authors":"M L Cohen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance is becoming an important public health problem for both hospital- and community-acquired infections. In the hospital, infections caused by drug-resistant Staphylococcus aureus, Mycobacterium tuberculosis, enterococci, and a variety of Gram-negative rods are resulting in increased morbidity, mortality and costs, in part because of prolonged hospitalization and the use of more expensive antimicrobial agents. Drug-resistant, community-acquired infections are also causing important problems in both the developed and the developing world. Although the relative importance of specific pathogens varies with the geographical area, community-acquired pathogens including Salmonella, Shigella, Neisseria gonorrhoeae, Haemophilus influenzae and Streptococcus pneumoniae are causing both sporadic cases and outbreaks of drug-resistant illness. The emergence of antimicrobial resistance is being attributed to a series of societal, technological, environmental and microbial changes. These include increasing populations of susceptible hosts, international travel and commerce, changes in technology and industry, microbial adaptation and change, and the breakdown of public health measures. Addressing emerging problems and antimicrobial resistance will require enhanced surveillance, prudent use of existing antimicrobial drugs, development of new antimicrobial agents, increased emphasis on infection control and hygienic practices, effective disease control programs, better use of existing vaccines, and development of more and better vaccines.</p>","PeriodicalId":10218,"journal":{"name":"Ciba Foundation symposium","volume":"207 ","pages":"223-31; discussion 231-7"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ciba Foundation symposium","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance is becoming an important public health problem for both hospital- and community-acquired infections. In the hospital, infections caused by drug-resistant Staphylococcus aureus, Mycobacterium tuberculosis, enterococci, and a variety of Gram-negative rods are resulting in increased morbidity, mortality and costs, in part because of prolonged hospitalization and the use of more expensive antimicrobial agents. Drug-resistant, community-acquired infections are also causing important problems in both the developed and the developing world. Although the relative importance of specific pathogens varies with the geographical area, community-acquired pathogens including Salmonella, Shigella, Neisseria gonorrhoeae, Haemophilus influenzae and Streptococcus pneumoniae are causing both sporadic cases and outbreaks of drug-resistant illness. The emergence of antimicrobial resistance is being attributed to a series of societal, technological, environmental and microbial changes. These include increasing populations of susceptible hosts, international travel and commerce, changes in technology and industry, microbial adaptation and change, and the breakdown of public health measures. Addressing emerging problems and antimicrobial resistance will require enhanced surveillance, prudent use of existing antimicrobial drugs, development of new antimicrobial agents, increased emphasis on infection control and hygienic practices, effective disease control programs, better use of existing vaccines, and development of more and better vaccines.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
影响抗菌药物耐药性出现的流行病学因素。
抗菌素耐药性正在成为医院和社区获得性感染的一个重要公共卫生问题。在医院里,由耐药金黄色葡萄球菌、结核分枝杆菌、肠球菌和各种革兰氏阴性杆状菌引起的感染导致发病率、死亡率和费用增加,部分原因是住院时间延长和使用更昂贵的抗菌剂。耐药的社区获得性感染也在发达国家和发展中国家造成重要问题。虽然特定病原体的相对重要性因地理区域而异,但社区获得性病原体,包括沙门氏菌、志贺氏菌、淋病奈瑟菌、流感嗜血杆菌和肺炎链球菌,正在引起散发病例和耐药疾病的暴发。抗菌素耐药性的出现可归因于一系列社会、技术、环境和微生物变化。这些因素包括易感宿主数量的增加、国际旅行和商业、技术和工业的变化、微生物适应和变化以及公共卫生措施的失效。解决新出现的问题和抗微生物药物耐药性需要加强监测、谨慎使用现有的抗微生物药物、开发新的抗微生物药物、更加强调感染控制和卫生做法、有效的疾病控制规划、更好地利用现有疫苗以及开发更多更好的疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Microdensitometry. Peptide metabolism. Local and collective motions in protein dynamics. The 'see-saw' theory of parturition. Salmonellosis: in retrospect and prospect.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1